The Cancer Letter

Inside information on cancer research and drug development

Vol.
28
No.
6
June 24, 2005Jun 24, 2005
Free
DOWNLOAD THE PDF

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

Irinotecan And Carboplatin Improve Response In NSCLC

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

Gemcitabine Improves DFS In Resected Pancreatic Cancer

Rosenberg: Immunotherapy May Have Broad Potential

NCI-Approved Clinical Trials

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account